We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Gout Beyond the Joints: What’s the Hidden Danger?
Richard Johnson, MD
Is Gout Hiding in the Nephrology Clinic?
Abdul Abdellatif, MD, FASN
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Is Managing Gout in the Nephrology Clinic a Challenge?
What’s New About Gout? Nephrology Perspective
Center of the Target: Which Patients Are Most Likely to Develop Gout?
2023 ESC Guideline Updates: Where Are We with Iron Deficiency?
Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
Marco Metra, MD
Gianluigi Savarese, MD
A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Maria Luiza Caramori, MD, PhD, MSc
Ana Maria Cebrián-Cuenca, MD, PhD
Pam R. Taub, MD, FACC, FASPC
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
Main Messages of New ESC Guidelines for CVD Management in Diabetes
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Stephen J. Greene, MD, FACC, FHFSA
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
Ovidiu Chioncel, MD, PhD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Jürgen Floege, MD
Loreto Gesualdo, MD, FERA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
Tessa Laubscher, MBChB, CCFP, FCFP
George L. Bakris, MD, FAHA, FASN
Mikhail Kosiborod, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education